Department of Vascular Surgery, Birmingham Heartlands Hospital, Birmingham, UK.
Renal Medicine, Heart of England NHS Foundation Trust, Birmingham, UK.
Nephrol Dial Transplant. 2018 May 1;33(5):841-846. doi: 10.1093/ndt/gfx278.
To study the effect of cannulation time on arteriovenous fistula (AVF) survival. Methods. Analysis of two prospective databases of access operations and dialysis sessions from 12 January 2002 through 4 January 2015 with follow-up until 4 January 2016. First cannulation time (FCT), defined from operation to first cannulation, was categorized as <2 weeks, 2-4 weeks, 4-8 weeks, 8-16 weeks and ≥16 weeks. Early cannulation was defined as FCT within 4 weeks. AVF survival was defined as the date until the AVF was abandoned. Maximum machine blood flow rate (BFR) for the first 29 dialysis sessions on AVF was analysed.
Altogether, 1167 AVF with functional dialysis use were analysed: 667 (57%) radial cephalic AVF, 383 (33%) brachiocephalic AVF and 117 (10%) brachiobasilic AVF. The 631 (54%) AVF created in on-dialysis patients were analysed separately from 536 (46%) AVF created in pre-dialysis patients. AVF survival was similar between cannulation categories for both pre-dialysis patients (P = 0.19) and on-dialysis patients (P = 0.83). Early cannulation was associated with similar AVF survival in both pre-dialysis patients (P = 0.82) and on-dialysis patients (P = 0.17). Six consecutive successful cannulations from the start were associated with improved AVF survival (P = 0.0002). A below-median BFR at the start of dialysis was associated with better AVF survival (P < 0.0001). A below-median increase in BFR in the first 2 months was associated with worse AVF survival (P = 0.007). The type of AVF, diabetes, pre-dialysis state at operation and six successful cannulations from the start were independent predictors for AVF survival.
FCT is not associated with AVF survival. Failures to achieve six successful cannulations from the start of dialysis and higher machine BFR in the first week of dialysis are associated with decreased AVF survival.
研究置管时间对动静脉瘘(AVF)生存的影响。方法。分析了 2002 年 1 月 12 日至 2015 年 1 月 4 日期间 12 个血管通路手术和透析治疗的前瞻性数据库,并随访至 2016 年 1 月 4 日。首次置管时间(FCT)定义为手术至首次置管的时间,分为<2 周、2-4 周、4-8 周、8-16 周和≥16 周。早期置管定义为 4 周内的 FCT。AVF 生存定义为 AVF 废弃的日期。分析首次 29 次透析时 AVF 的最大机器血流速度(BFR)。
共分析了 1167 例有功能透析使用的 AVF:667 例(57%)桡动脉头静脉 AVF、383 例(33%)肱动脉头静脉 AVF 和 117 例(10%)肱动脉正中静脉 AVF。在透析患者中创建的 631 例(54%)AVF 与在透析前患者中创建的 536 例(46%)AVF 分别进行了分析。在透析前患者(P=0.19)和在透析患者(P=0.83)中,不同置管时间的 AVF 生存率相似。在透析前患者(P=0.82)和在透析患者(P=0.17)中,早期置管与相似的 AVF 生存率相关。从开始的连续 6 次成功置管与 AVF 生存率提高相关(P=0.0002)。开始透析时 BFR 低于中位数与更好的 AVF 生存率相关(P<0.0001)。前 2 个月 BFR 增加低于中位数与 AVF 生存率下降相关(P=0.007)。AVF 类型、糖尿病、手术前的透析状态和从开始的 6 次成功置管是 AVF 生存的独立预测因素。
FCT 与 AVF 生存率无关。未能从透析开始时实现 6 次成功置管以及透析第 1 周机器 BFR 较高与 AVF 生存率降低有关。